Joyce Fingeroth to Herpesvirus 4, Human
This is a "connection" page, showing publications Joyce Fingeroth has written about Herpesvirus 4, Human.
Connection Strength
2.529
-
Arredouani MS, Bhasin MK, Sage DR, Dunn LK, Gill MB, Agnani D, Libermann TA, Fingeroth JD. Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection. J Virol. 2014 May; 88(10):5559-77.
Score: 0.400
-
Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD. Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor. Cell Rep. 2013 Feb 21; 3(2):371-85.
Score: 0.372
-
Gill MB, Kutok JL, Fingeroth JD. Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles. J Virol. 2007 Jun; 81(12):6523-35.
Score: 0.248
-
Gill MB, Roecklein-Canfield J, Sage DR, Zambela-Soediono M, Longtine N, Uknis M, Fingeroth JD. EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21. J Cell Sci. 2004 Jun 01; 117(Pt 13):2709-20.
Score: 0.203
-
Prota AE, Sage DR, Stehle T, Fingeroth JD. The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10641-6.
Score: 0.179
-
Ahmadi E, Ravanshad M, Xie J, Panigrahi R, Jubbal SS, Guru SK, Guangping G, Ziyaeyan M, Fingeroth J. Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein-Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV?+?lymphoproliferative disorders. Virol J. 2021 11 18; 18(1):223.
Score: 0.171
-
Fingeroth JD, Diamond ME, Sage DR, Hayman J, Yates JL. CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J Virol. 1999 Mar; 73(3):2115-25.
Score: 0.141
-
Gustafson EA, Chillemi AC, Sage DR, Fingeroth JD. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase. Antimicrob Agents Chemother. 1998 Nov; 42(11):2923-31.
Score: 0.138
-
Hu H, Luo ML, Desmedt C, Nabavi S, Yadegarynia S, Hong A, Konstantinopoulos PA, Gabrielson E, Hines-Boykin R, Pihan G, Yuan X, Sotiriou C, Dittmer DP, Fingeroth JD, Wulf GM. Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation. EBioMedicine. 2016 Jul; 9:148-160.
Score: 0.117
-
Kuhn-Hallek I, Sage DR, Stein L, Groelle H, Fingeroth JD. Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells. Blood. 1995 Mar 01; 85(5):1289-99.
Score: 0.107
-
Sun X, Bristol JA, Iwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC. Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. J Virol. 2013 Sep; 87(18):10126-38.
Score: 0.096
-
Meng Q, Hagemeier SR, Fingeroth JD, Gershburg E, Pagano JS, Kenney SC. The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production. J Virol. 2010 May; 84(9):4534-42.
Score: 0.076
-
Fingeroth JD, Clabby ML, Strominger JD. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J Virol. 1988 Apr; 62(4):1442-7.
Score: 0.066
-
Paulson EJ, Fingeroth JD, Yates JL, Speck SH. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. Virology. 2002 Jul 20; 299(1):109-21.
Score: 0.045
-
Heng YJ, Love S, DeHart JC, Fingeroth JD, Wulf GM. The association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study?. Breast Cancer. 2022 Jul; 29(4):731-739.
Score: 0.044
-
Gustafson EA, Schinazi RF, Fingeroth JD. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir. J Virol. 2000 Jan; 74(2):684-92.
Score: 0.037
-
Marshall WL, Yim C, Gustafson E, Graf T, Sage DR, Hanify K, Williams L, Fingeroth J, Finberg RW. Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol. 1999 Jun; 73(6):5181-5.
Score: 0.036
-
Mentzer SJ, Fingeroth J, Reilly JJ, Perrine SP, Faller DV. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma. Blood Cells Mol Dis. 1998 Jun; 24(2):114-23.
Score: 0.034
-
Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A. 1984 Jul; 81(14):4510-4.
Score: 0.013
-
Mentzer SJ, Longtine J, Fingeroth J, Reilly JJ, DeCamp MM, O'Donnell W, Swanson SJ, Faller DV, Sugarbaker DJ. Immunoblastic lymphoma of donor origin in the allograft after lung transplantation. Transplantation. 1996 Jun 27; 61(12):1720-5.
Score: 0.007